Benefits
DashboardNot registered yet? Get a free account.
Sign UpNot registered yet? Get a free account.
Sign Up
You're about to leave our website and go to an external link. Are you sure?
Suven Pharmaceuticals Limited, is an unlisted public company incorporated on 06 November, 2018. It is classified as a public limited company and is located in Hyderabad, Telangana. It's authorized share capital is INR 40.00 cr and the total paid-up capital is INR 25.46 cr.
Suven Pharmaceuticals Limited's operating revenue range is Over INR 500 cr for the financial year ending on 31 March, 2023. It's EBITDA has increased by 0.53% over the previous year. At the same time, it's book networth has increased by 15.04%.
Read more
Buy Dashboard using Credits
This action will use 1 of your credits. Are you sure you want to go ahead?
Credits Balance:
0
** All rupee values in INR crores. Based on March 2023 numbers.
0.75%
0.53%
-22.49%
15.04%
-27.63%
8.5%
0.13
-0.09
-5.54
-11.97
-0.38
-0.02
Buy Report or Plans
Company dashboard
Five year financials and ratios
Risk analysis
Interactive charts
All financials
All annual returns
MoA and AoA
Latest financials
Latest annual return
MoA and AoA
Five year financials and ratios
Shareholding and group structure
Litigation and more
Everything in financial report
Peers and financials
* GST not included
** Reports & MCA filings will be based on the latest available financials.
India
(8)
| State | Type | Address |
|---|
Locations on Map
Filter (4)
Severe Risk
Moderate Risk
Low Risk
Read more
| Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | |
|---|---|---|---|---|---|
| Sales | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Operating profit | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Net profit | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Gross margin | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Operating margin | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Net margin | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Networth | |||||
| Borrowings | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Debt to equity | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Current ratio | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| ROE | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Days payable | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| WC days | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | |
|---|---|---|---|---|---|
| Equity Capital | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Reserves | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Borrowings + | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Long term borrowings | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Short term borrowings | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Trade payables + | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Days payable | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Other liabilities + | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Other non-current liabilities | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Other current liabilities | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Total liabilities | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Fixed Assets + | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Tangible assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| CWIP | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Intangible assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| LT loans and advances | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Other non-current assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Current assets + | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Inventories | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Trade receivables | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Cash and cash equivalents | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| ST loans and advances | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Other current assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Total assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | |
|---|---|---|---|---|---|
| Sales + | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Sales growth % | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Expenses + | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Cost of goods | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Employee cost | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Other costs | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Operating profit + | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Operating margin % | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Other income | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Interest | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Depreciation | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Exceptional items | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Profit before tax | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Tax | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Profit - disc. ops | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Net profit | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Net margin % | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | |
|---|---|---|---|---|---|
| Solvency + | |||||
| Total Debt/Equity | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Net Debt/Equity | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Total Debt/Assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Total Assets/Equity | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Liquidity + | |||||
| Current Ratio | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Quick Ratio | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Interest Coverage | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Performance | |||||
| Gross Margin | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Operating Margin | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Net Margin | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Return + | |||||
| Return on Equity | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Pre-tax ROCE | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Return on Assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Pre-tax ROIC | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Efficiency + | |||||
| Days Payable | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Days Inventory | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Days Receivable | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Fixed Asset Turnover | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Total Asset Turnover | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Working Capital | |||||
| Cash Conversion Cycle | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Working Capital Days | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
State Bank of India
No. of Loans: 1
Total Amount : 67.0 cr
BANK OF BAHRAIN AND KUWAIT BSC
No. of Loans: 1
Total Amount : 10.0 cr
| Designation | Name | DIN/PAN | Tenure |
|---|---|---|---|
| Director | Kumarapuram Gopalakrishnan Ananthakrishnan | 00019325 | 1 years |
| Director | Shweta Jalan | 00291675 | 1 years |
| Director | Annaswamy Vaidheesh | 01444303 | 1 years |
| Director | Matangi Gowrishankar | 01518137 | 1 years |
| Director | Vinod Rao | 01788921 | 1 years |
| Kmp | Sudhir Kumar Singh | <HIDDEN> | 1 years |
| Kmp | Himanshu Agarwal | <HIDDEN> | 1 years |
| Director | Pravin Udhyavara Bhadya Rao | 06782450 | 1 years |
| Director | Venkatanaga Kali Vara Prasada Raju Vetukuri | 07267366 | 1 years |
| Director | Pankaj Patwari | 08206620 | 1 years |
| CS | Hanumantha Rao Kokkonda | <HIDDEN> | 5 years |
| Name | Status | Paid up Capital | Common Directors | Address |
|---|---|---|---|---|
| SAPALA ORGANICS PRIVATE LIMITED |
Active
|
12.5 Cr | 2 | Telangana |
| YES BANK LIMITED |
Active
|
6,269.4 Cr | 1 | Maharashtra |
| COHANCE LIFESCIENCES LIMITED |
Active
|
3,394.7 Cr | 3 | Maharashtra |
| BHARAT SERUMS AND VACCINES LIMITED |
Amalgamated
|
9.0 Cr | 2 | Maharashtra |
| ZCL CHEMICALS LIMITED |
Amalgamated
|
9.1 Cr | 2 | Maharashtra |
| RA CHEM PHARMA LIMITED |
Amalgamated
|
8.5 Cr | 3 | Andhra Pradesh |
| BHARAT SERUMS AND VACCINES LIMITED |
Active
|
73.1 L | 2 | Maharashtra |
| MANJUSHREE TECHNOPACK LIMITED |
Active
|
13.7 Cr | 2 | Karnataka |
| MODENIK LIFESTYLE PRIVATE LIMITED |
Active
|
34.4 Cr | 1 | Karnataka |
| NORTH STAR ASIA LLP |
Active
|
50,000.0 | 1 | Maharashtra |
| UNIVERSAL NUTRISCIENCE PRIVATE LIMITED |
Active
|
230.9 Cr | 1 | Maharashtra |
| AKUMS DRUGS AND PHARMACEUTICALS LIMITED |
Active
|
31.5 Cr | 1 | Delhi |
| INTELLECASH MICROFINANCE NETWORK COMPANY PRIVATE LIMITED |
Amalgamated
|
11.2 Cr | 1 | Maharashtra |
| GUJARAT PIPAVAV PORT LIMITED |
Active
|
483.4 Cr | 1 | Gujarat |
| PREMIUM MOTION PRIVATE LIMITED |
Active
|
2.0 Cr | 1 | Maharashtra |
| PREMIUM TRANSMISSION PRIVATE LIMITED |
Active
|
112.5 Cr | 1 | Maharashtra |
| CYIENT LIMITED |
Active
|
55.5 Cr | 1 | Telangana |
| IDFC FIRST BANK LIMITED |
Active
|
7,316.3 Cr | 1 | Tamil Nadu |
| INTELLECAP ADVISORY SERVICES PRIVATE LIMITED |
Active
|
51.4 L | 1 | Maharashtra |
| GABRIEL INDIA LIMITED |
Active
|
14.4 Cr | 1 | Maharashtra |
| GREENLAM INDUSTRIES LIMITED |
Active
|
12.8 Cr | 1 | Delhi |
| EUREKA FORBES LIMITED |
Active
|
193.5 Cr | 1 | Maharashtra |
| ZENSAR TECHNOLOGIES LIMITED |
Active
|
45.3 Cr | 1 | Maharashtra |
| COMPUTER AGE MANAGEMENT SERVICES LIMITED |
Active
|
49.2 Cr | 1 | Tamil Nadu |
| INDEGENE LIMITED |
Active
|
47.9 Cr | 1 | Karnataka |
| AXIS FINANCE LIMITED |
Active
|
627.1 Cr | 1 | Maharashtra |
| SOWPARNIKA RETAIL PRIVATE LIMITED |
Active
|
1.0 L | 1 | Karnataka |
| GIL LIFESCIENCES PRIVATE LIMITED |
Amalgamated
|
13.8 Cr | 1 | Telangana |
| INISPIRE HEALTHCARE SOLUTIONS PRIVATE LIMITED |
Active
|
1.0 L | 1 | Telangana |
| CASPER PHARMA PRIVATE LIMITED |
Active
|
26.1 Cr | 1 | Telangana |
| AVRA LABORATORIES PRIVATE LIMITED |
Amalgamated
|
7.0 Cr | 1 | Maharashtra |
| KEIMED PRIVATE LIMITED |
Active
|
6.8 Cr | 1 | Telangana |
| GOKALDAS INTIMATEWEAR PRIVATE LIMITED |
Amalgamated
|
30.5 Cr | 1 | Karnataka |
| APOLLO HEALTHCO LIMITED |
Active
|
2,884.9 Cr | 1 | Tamil Nadu |
| ADVENT INDIA PE ADVISORS PRIVATE LIMITED |
Active
|
2.2 Cr | 1 | Maharashtra |
| Name | State / Country | Incorporation Year | Paidup Capital |
|---|---|---|---|
| SUVEN PHARMA INC | United States | - | - |
The incorporation date of SUVEN PHARMACEUTICALS LIMITED is 06 November, 2018
The authorized share capital of SUVEN PHARMACEUTICALS LIMITED is INR ₹ 40.0 Cr.
The paid-up capital of SUVEN PHARMACEUTICALS LIMITED is INR ₹ 25.5 Cr.
The registered address of SUVEN PHARMACEUTICALS LIMITED is # 8-2-334, SDE SERENE CHAMBERS, 3rd FLOOR AVENUE 7, ROAD NO. 5, BANJARA HILLS HYDERABAD Hyderabad Telangana - 500034
The CIN number of SUVEN PHARMACEUTICALS LIMITED is L24299TG2018PLC128171.
Expand
Delete
Collapse
See
details
It will take sometime. Please come back in 10
minutes
